Pregnancy with a prosthetic heart valve, thrombosis, and bleeding: the ESC EORP Registry of Pregnancy and Cardiac disease III

European Heart Journal

16 April 2025
Organised by: Logo
ESC Journals VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Congenital Heart Disease and Paediatric Cardiology Valvular Heart Disease

Abstract

AbstractBackground and Aims

Pregnancy in women with a prosthetic heart valve is considered high risk, primarily due to the need for effective anticoagulation. However, data on the relationship between anticoagulation practices and pregnancy outcomes are very limited.

Methods

The Registry of Pregnancy and Cardiac disease is a global registry that prospectively enrolled pregnancies in women with a prosthetic heart valve between January 2018 and April 2023. Detailed data on anticoagulation, including dosage and monitoring, and cardiovascular, pregnancy, and perinatal outcomes were collected.

Results

In total, 613 pregnancies were included of which 411 pregnancies were in women with a mechanical valve and 202 were in women with a biological valve. The chance of an uncomplicated pregnancy with a live birth in women with a mechanical valve was 54%, compared with 79% in women with a biological valve (P < .001). Thromboembolic and haemorrhagic complications most frequently occurred when low-molecular weight heparin (LMWH)–based regimens were used. Valve thrombosis occurred in 24 (6%) women, and a prosthetic valve in mitral position was associated with valve thrombosis (odds ratio 3.3; 95% confidence interval 1.9–8.0). A thromboembolic event occurred in 12 (10%) women with anti-Xa monitoring and in 9 (21%) women without (P = .060). Foetal death occurred in 20% of all pregnancies.

Conclusions

More favourable outcomes were found in women with a biological valve compared with a mechanical valve. In women with a mechanical valve, the use of LMWH was associated with an increased risk of thromboembolic complications. A mitral prosthetic valve was identified as a predictor for valve thrombosis. The benefit could not be confirmed nor refuted, in terms of reduced thromboembolic events, from using anti-Xa level monitoring in women on LMWH.

Contributors

J Grewal
J Grewal

Author

M Janzen
M Janzen

Author

Karishma P Ramlakhan
Karishma P Ramlakhan

Author

Erasmus University Medical Centre Rotterdam , Netherlands (The)

Karen Sliwa
Karen Sliwa

Author

Cape Heart Institute, University of Cape Town Cape Town , South Africa

K Sorour
K Sorour

Author

S Abebe
S Abebe

Author

C Fekadu
C Fekadu

Author

D Yadeta
D Yadeta

Author

Jolien W Roos-Hesselink
Jolien W Roos-Hesselink

Author

Erasmus University Medical Centre Rotterdam , Netherlands (The)

L Eliaou
L Eliaou

Author

Y Dulac
Y Dulac

Author

E Zengin
E Zengin

Author

J Harris
J Harris

Author

K Kannan
K Kannan

Author

W Budts
W Budts

Author

E Troost
E Troost

Author

L Roggen
L Roggen

Author

E Tefera
E Tefera

Author

L Kontle
L Kontle

Author

C Ciuca
C Ciuca

Author

F Marchi
F Marchi

Author

M Baroni
M Baroni

Author

P Festa
P Festa

Author

F Fusco
F Fusco

Author

M Merlo
M Merlo

Author

M Bobbo
M Bobbo

Author

F Ramani
F Ramani

Author

A Pagano
A Pagano

Author

F Petey
F Petey

Author

B Bouma
B Bouma

Author

D Segers
D Segers

Author

A Evers
A Evers

Author

T Schaap
T Schaap

Author

K Bano
K Bano

Author

K Amir
K Amir

Author

N Patel
N Patel

Author

P Akhter
P Akhter

Author

R Khan
R Khan

Author

S Mahar
S Mahar

Author

S Habib
S Habib

Author

T Mano
T Mano

Author

M Selas
M Selas

Author

W Kurdi
W Kurdi

Author

O Vriz
O Vriz

Author

O Ahmad
O Ahmad

Author

B Alamro
B Alamro

Author

K Sliwa
K Sliwa

Author

B Gordon
B Gordon

Author

E Nagy
E Nagy

Author

T Achter
T Achter

Author

K Junus
K Junus

Author

D Tobler
D Tobler

Author

F Brand
F Brand

Author

T Rutz
T Rutz

Author

F Brand
F Brand

Author

N Ozer
N Ozer

Author

Z Bugra
Z Bugra

Author

B Umman
B Umman

Author

D Baykiz
D Baykiz

Author

D Mutlu
D Mutlu

Author

H Yalman
H Yalman

Author

D Oksen
D Oksen

Author

O Mazur
O Mazur

Author

S Wani
S Wani

Author

R Afifi
R Afifi

Author

A Cecchi
A Cecchi

Author

G Wells
G Wells

Author

D Sparks
D Sparks

Author

W Wagner
W Wagner

Author

R Saxena
R Saxena

Author

R Gobar
R Gobar

Author

J Chou
J Chou

Author

R Elder
R Elder

Author

N Bhalla
N Bhalla

Author

A Small
A Small

Author

P Panday
P Panday

Author

J Porche
J Porche

Author

S Stack
S Stack

Author

A Khan
A Khan

Author

E Pare
E Pare

Author

P Woods
P Woods

Author

A Cove
A Cove

Author

N Mann
N Mann

Author

ESC 365 is supported by